The Centers for Disease Control and Prevention and Food and Drug Administration are alerting health care providers to a nationwide recall of Diocto Liquid and Diocto Syrup, a stool softener used in inpatient and outpatient settings. The docusate sodium solutions, manufactured by PharmaTech LLC and distributed by Rugby Laboratories, may be contaminated with Burkholderia cepacia, which can cause serious or life-threatening infections in patients with compromised immune systems or chronic lung conditions. All lots with NDC 0536-0590-85 and NDC 0536-1001-85 are included in this voluntary recall.Consumers, pharmacies, and health care facilities should stop using and dispensing product from these lots immediately, according to FDA. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program at www.fda.gov/medwatch/report.htm. See the FDA notice for further details.

Related News Articles

Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Sept. 30 to review their 2016 quality data before it is publicly reported on the…
Headline
The Institute for Safe Medication Practices yesterday released a tool to help hospitals and outpatient facilities evaluate their safety practices for “…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 20 on a “new direction” for its Innovation Center that will approach…